Systemic mastocytosis is a rare, clonal mast cell neoplasm driven by the KIT D816V mutation [1] that is characterized by uncontrolled proliferation and activation of mast cells, which leads to severe and unpredictable symptoms for patients with systemic mastocytosis [2]. Here, KIT is linked to systemic mastocytosis.